# Universidad San Carlos

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/universidad-san-carlos/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 47 |
| Citations | 23,008 |
| City | Asunción |
| Country | PY |
| Description | Universidad San Carlos is a research organisation in Asunción, PY. OpenAlex records 1,374 works and 23,008 citations for it. 709 researchers list it as their most recent affiliation. |
| Homepage | http://www.sancarlos.edu.py/ |
| OpenAlex ID | https://openalex.org/I4210151393 |
| Researchers | 709 |
| ROR ID | https://ror.org/05b1ymr19 |
| Type | education |
| Works | 1,374 |

## University papers

Showing 12 of 58.

- [EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib](https://scholariq.org/papers/egf-receptor-gene-mutations-are-common-in-lung-cancers-from-never-smokers-and/)
- [Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden](https://scholariq.org/papers/analysis-of-100-000-human-cancer-genomes-reveals-the-landscape-of-tumor/)
- [Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain](https://scholariq.org/papers/acquired-resistance-of-lung-adenocarcinomas-to-gefitinib-or-erlotinib-is/)
- [Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers](https://scholariq.org/papers/analysis-of-tumor-specimens-at-the-time-of-acquired-resistance-to-egfr-tki/)
- [Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers](https://scholariq.org/papers/tumor-mutational-burden-as-an-independent-predictor-of-response-to-immunotherapy/)
- [Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing](https://scholariq.org/papers/development-and-validation-of-a-clinical-cancer-genomic-profiling-test-based-on/)
- [Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing](https://scholariq.org/papers/mapping-the-hallmarks-of-lung-adenocarcinoma-with-massively-parallel-sequencing/)
- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib](https://scholariq.org/papers/i-met-i-amplification-occurs-with-or-without-i-t790m-i-mutations-in-i-egfr-i/)
- [KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib](https://scholariq.org/papers/kras-mutations-and-primary-resistance-of-lung-adenocarcinomas-to-gefitinib-or/)
- [TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/tribute-a-phase-iii-trial-of-erlotinib-hydrochloride-osi-774-combined-with/)
- [Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer](https://scholariq.org/papers/activation-of-the-axl-kinase-causes-resistance-to-egfr-targeted-therapy-in-lung/)

## University researchers

- [Kaijun Wang](https://scholariq.org/researchers/kaijun-wang-2/)
- [Boxiong Tang](https://scholariq.org/researchers/boxiong-tang/)
- [Bálint File](https://scholariq.org/researchers/balint-file/)

## University top topics

Showing 8 of 10.

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)
- [Mathematics Education and Teaching Techniques](https://scholariq.org/topics/mathematics-education-and-teaching-techniques/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Technology-Enhanced Education Studies](https://scholariq.org/topics/technology-enhanced-education-studies/)
- [Educational Innovations and Technology](https://scholariq.org/topics/educational-innovations-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.